Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.52 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.52 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.52 |
| ▸ | CA1 | P00915 | 3/20 | 0.52 |
| ▸ | CA2 | P00918 | 3/20 | 0.52 |
| ▸ | CA9 | Q16790 | 2/20 | 0.52 |
| ▸ | FAAH | O00519 | 1/20 | 0.52 |
| ▸ | ELANE | P08246 | 1/20 | 0.52 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.52 |
| ▸ | CA5A | P35218 | 1/20 | 0.52 |
| ▸ | F2 | P00734 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | MMP1 | P03956 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | MMP9 | P14780 | 1/20 | 0.47 |
| ▸ | MMP8 | P22894 | 1/20 | 0.47 |
| ▸ | MMP13 | P45452 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28137631 | 0.98 | KMT2A (0.59) | KMT2APRSS1PRSS2PRSS3CA1 | |
| Nitrobenzene SCHEMBL27350133 | 0.86 | HTT (0.65) | KMT2AHTTMMP2TXNRD1ALDH1A1 | |
| SCHEMBL27977269 | 0.86 | TXNRD1 (0.53) | KMT2AHTTTXNRD1ALDH1A1MAPK1 | |
| SCHEMBL12474258 | 0.83 | AGXT (0.47) | KMT2ACA1CA2CA9 | |
| SCHEMBL29245395 | 0.83 | KMT2A (0.57) | KMT2APRSS1PRSS2PRSS3CA1 | |
| Dinitrophenylene SCHEMBL27894426 | 0.82 | HTT (0.56) | KMT2AHTTALDH1A1MAPK1TSHR | |
| SCHEMBL1972890 | 0.81 | KMT2A (0.65) | KMT2APRSS1PRSS2PRSS3CA1 | |
| SCHEMBL28509967 | 0.80 | CA2 (0.47) | KMT2ACA2F2HTTALDH1A1 | |
| SCHEMBL14370973 | 0.80 | CA1 (0.47) | KMT2ACA1CA2CA9TXNRD1 | |
| SCHEMBL6916202 | 0.79 | KMT2A (0.53) | KMT2APRSS1PRSS2PRSS3CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4602358-A1 | COMPOSITION AND METHOD FOR MEASURING CALCIUM HARDNESS IN PROCESS WATER | Ecolab USA Inc. (US) | 2025-08-20 | — | — | EP | claimed |
| WO-2024081636-A1 | COMPOSITION AND METHOD FOR MEASURING CALCIUM HARDNESS IN PROCESS WATER | ECOLAB USA INC. (US) | 2024-04-18 | — | — | WO | claimed |
| US-20240125753-A1 | COMPOSITION AND METHOD FOR MEASURING CALCIUM HARDNESS IN PROCESS WATER | ECOLAB USA INC. | 2024-04-18 | — | — | US | claimed |
| EP-4324928-A1 | SYNTHETIC REAGENTS FOR ENZYME-CATALYSED ALKYLATION | Universität Basel (CH) | 2024-02-21 | — | — | EP | claimed |
| US-10351562-B2 | Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound | ADVERIO PHARMA GMBH (DE) | 2019-07-16 | — | — | US | claimed |
| US-20180282329-A1 | PROCESS FOR PREPARING METHYL {4,6-DIAMINO-2-[1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL]PYRIMIDIN-5-YL}METHYLCARBAMATE AND ITS PURIFICATION FOR USE AS PHARMACEUTICALLY ACTIVE COMPOUND | ADVERIO PHARMA GMBH (DE) | 2018-10-04 | — | — | US | claimed |
| EP-2444390-B1 | Process for producing Lacosamide | EUTICALS GMBH (DE) | 2017-02-01 | — | — | EP | claimed |
| EP-2861643-A1 | LATENT CATALYST FOR CURABLE COMPOSITIONS | Dow Global Technologies LLC (US) | 2015-04-22 | — | — | EP | claimed |
| US-20150087748-A1 | LATENT CATALYST FOR CURABLE COMPOSITIONS | BLUE CUBE IP LLC | 2015-03-26 | — | — | US | claimed |
| US-8927634-B2 | Phthalate-free isocyanurate formulations | LANXESS DEUTSCHLAND GMBH (DE) | 2015-01-06 | — | — | US | claimed |
| CN-1385919-A | Electrolyte for lithium secondary battery and lithium secondary battery containing the same | SAMSUNG SDI CO LTD (KR) | 2002-12-18 | — | — | CN | claimed |
| US-20020107318-A1 | Resin Composition | NICHIAS CORPORATION (JP) | 2002-08-08 | — | — | US | claimed |
| US-6291577-B1 | ADMIXING WITH POLYISOCYANATE A MOISTURE SCAVENGING COMPOUND SUCH AS 2,6-DITERTIARYBUTYL HYDROXYTOLUENE AND 2-TERTIARYBUTYL HYDROXYTOLUENE AND ALKYL ESTER TOLUENESULFONIC ACID AND SOLVENT | RHODIA INC. | 2001-09-18 | — | — | US | claimed |
| EP-1029893-A2 | Resin composition | NICHIAS CORPORATION (JP) | 2000-08-23 | — | — | EP | claimed |
| US-5286787-A | Adding reactive polysiloxane, weatherproofing | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1994-02-15 | — | — | US | claimed |
| US-5225547-A | Using an alkylation reagent and disubstituted formamide or acid amide as promoters | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1993-07-06 | — | — | US | claimed |
| EP-0216505-B1 | POLYIMIDES, PREPARATION OF POLYIMIDES AND BLENDS OF POLYIMIDES | ROHM AND HAAS COMPANY (US) | 1993-02-24 | — | — | EP | claimed |
| US-4882095-A | Preparation of alkoxy(iso)violanthrenediones | BASF AKTIENGESELLSCHAFT (DE) | 1989-11-21 | — | — | US | claimed |
| EP-0216505-A2 | Polyimides, preparation of polyimides and blends of polyimides | ROHM AND HAAS COMPANY (US) | 1987-04-01 | — | — | EP | claimed |
| US-4051168-A | TO FORM FLUOROALKYL AROMATIC COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-09-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180282329-A1 | PROCESS FOR PREPARING METHYL {4,6-DIAMINO-2-[1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL]PYRIMIDIN-5-YL}METHYLCARBAMATE AND ITS PURIFICATION FOR USE AS PHARMACEUTICALLY ACTIVE COMPOUND | TPMT, AMD1, DPYD | KMT2A 534/4885PRSS1 1054/4885PRSS2 1913/4885 |
| US-10351562-B2 | Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound | TPMT, AMD1, DPYD | KMT2A 603/4885PRSS1 1103/4885PRSS2 1972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.